US Patent Issued to AMPHISTA THERAPEUTICS on May 12 for "Compounds for targeted protein degradation" (British Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,035, issued on May 12, was assigned to AMPHISTA THERAPEUTICS Ltd. (Cambridge, Great Britain).

"Compounds for targeted protein degradation" was invented by David Mcgarry (Cambridge, Great Britain), Giles Albert Brown (Cambridge, Great Britain) and Pauline Drouhin (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides a compound of formula (III): or a pharmaceutically acceptable salt, solvate or derivative thereof, wherein the substituents are as defined herein. The disclosure also provides pharmaceutical compositions comprising said compounds and the use of said compounds in the treatment of diseases, e.g. ca...